These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9602956)

  • 1. Lack of effect of food on the oral bioavailability of irbesartan in healthy male volunteers.
    Vachharajani NN; Shyu WC; Mantha S; Park JS; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1998 May; 38(5):433-6. PubMed ID: 9602956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic properties and bioequivalence of two irbesartan/ hydrochlorothiazide fixed-dose combination tablets in healthy male Chinese volunteers.
    Liu J; Wu L; Hu X; Wu G; Zheng Y; Zhou H; Zhai Y; Zhu M; ShenTu J
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):573-81. PubMed ID: 25828636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the pharmacokinetics and relative bioavailability of irbesartan capsules in healthy volunteers.
    Gu S; Chen H; Qiu Y; Shi S; Zeng F
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):14-6. PubMed ID: 12658772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
    Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
    Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of irbesartan in hypertensive children and adolescents.
    Sakarcan A; Tenney F; Wilson JT; Stewart JJ; Adcock KG; Wells TG; Vachharajani NN; Hadjilambris OW; Slugg P; Ford NF; Marino MR
    J Clin Pharmacol; 2001 Jul; 41(7):742-9. PubMed ID: 11452706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different meal compositions on the oral bioavailability of treprostinil diolamine in healthy volunteers.
    Lim A; Wang-Smith L; Kates J; Laurent A; Kumar P; Laliberte K
    J Clin Pharm Ther; 2013 Dec; 38(6):450-5. PubMed ID: 23927483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability of two irbesartan/hydrochlorothiazide tablet formulations in Indonesian healthy subjects.
    Sasongko L; Harahap Y; Prasaja B; Lusthom W; Setiawan EC; Meliala RS; Lipin
    Arzneimittelforschung; 2010; 60(12):749-53. PubMed ID: 21265466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects.
    Marino MR; Langenbacher K; Ford NF; Uderman HD
    J Clin Pharmacol; 1998 Mar; 38(3):246-55. PubMed ID: 9549663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2C9 3 and 13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects.
    Choi CI; Kim MJ; Chung EK; Lee HI; Jang CG; Bae JW; Lee SY
    Eur J Clin Pharmacol; 2012 Feb; 68(2):149-54. PubMed ID: 21842338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers.
    Vachharajani NN; Shyu WC; Chando TJ; Everett DW; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1998 Aug; 38(8):702-7. PubMed ID: 9725545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques.
    Davi H; Tronquet C; Miscoria G; Perrier L; DuPont P; Caix J; Simiand J; Berger Y
    Drug Metab Dispos; 2000 Jan; 28(1):79-88. PubMed ID: 10611144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of irbesartan in man.
    Chando TJ; Everett DW; Kahle AD; Starrett AM; Vachharajani N; Shyu WC; Kripalani KJ; Barbhaiya RH
    Drug Metab Dispos; 1998 May; 26(5):408-17. PubMed ID: 9571222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics and pharmacodynamics of irbesartan in heart failure.
    Kostis JB; Vachharajani NN; Hadjilambris OW; Kollia GD; Palmisano M; Marino MR
    J Clin Pharmacol; 2001 Sep; 41(9):935-42. PubMed ID: 11549097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PK-PD modeling of irbesartan in healthy Chinese adult volunteers under non-steady-state conditions.
    Huang XH; Li J; Qiu FR; Xie HT; Huang JH; Li JC; Zheng QS
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):259-64. PubMed ID: 17315536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual and joint association of alpha1A-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects.
    Jiang S; Mao G; Zhang S; Hong X; Tang G; Li Z; Liu X; Zhang Y; Wang B; Xu X; Wang X
    Clin Pharmacol Ther; 2005 Sep; 78(3):239-48. PubMed ID: 16153395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
    Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of age and gender on the pharmacokinetics of irbesartan.
    Vachharajani NN; Shyu WC; Smith RA; Greene DS
    Br J Clin Pharmacol; 1998 Dec; 46(6):611-3. PubMed ID: 9862252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence study of two oral formulations of irbesartan 300 mg in healthy volunteers.
    Cánovas M; Cabré F; Polonio F
    Drug Res (Stuttg); 2014 Jan; 64(1):53-6. PubMed ID: 24048950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cigarette smoking with steady-state plasma concentration of irbesartan in male Chinese with hypertension.
    Zhang S; Liu P; Jiang S; Hong X; Xing H; Xu X
    Methods Find Exp Clin Pharmacol; 2005 Apr; 27(3):173-8. PubMed ID: 15834449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.